Merck & Co., Inc. (MRK)
143.93
-0.78
(-0.54%)
USD |
NYSE |
Sep 11, 16:00
144.00
+0.07
(+0.05%)
After-Hours: 20:00
Merck Net Income (Quarterly) : -1.337B for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.337B |
| March 31, 2026 | -4.243B |
| December 31, 2025 | 2.962B |
| September 30, 2025 | 5.787B |
| June 30, 2025 | 4.428B |
| March 31, 2025 | 5.085B |
| December 31, 2024 | 3.745B |
| September 30, 2024 | 3.161B |
| June 30, 2024 | 5.461B |
| March 31, 2024 | 4.767B |
| December 31, 2023 | -1.225B |
| September 30, 2023 | 4.75B |
| June 30, 2023 | -5.972B |
| March 31, 2023 | 2.825B |
| December 31, 2022 | 3.018B |
| September 30, 2022 | 3.253B |
| June 30, 2022 | 3.949B |
| March 31, 2022 | 4.307B |
| December 31, 2021 | 3.824B |
| September 30, 2021 | 4.571B |
| June 30, 2021 | 1.214B |
| March 31, 2021 | 2.749B |
| December 31, 2020 | -2.614B |
| September 30, 2020 | 2.326B |
| June 30, 2020 | 2.345B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.219B |
| December 31, 2019 | 2.364B |
| September 30, 2019 | 1.907B |
| June 30, 2019 | 2.644B |
| March 31, 2019 | 2.862B |
| December 31, 2018 | 1.778B |
| September 30, 2018 | 1.958B |
| June 30, 2018 | 1.716B |
| March 31, 2018 | 741.00M |
| December 31, 2017 | -1.038B |
| September 30, 2017 | -51.00M |
| June 30, 2017 | 1.951B |
| March 31, 2017 | 1.556B |
| December 31, 2016 | -587.00M |
| September 30, 2016 | 2.188B |
| June 30, 2016 | 1.209B |
| March 31, 2016 | 1.13B |
| December 31, 2015 | 981.00M |
| September 30, 2015 | 1.831B |
| June 30, 2015 | 688.00M |
| March 31, 2015 | 958.00M |
| December 31, 2014 | 7.327B |
| September 30, 2014 | 842.00M |
| June 30, 2014 | 2.033B |
| March 31, 2014 | 1.731B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
| Pfizer Inc. | -246.00M |
| Bristol Myers Squibb Co. | 3.316B |
| Viatris, Inc. | -118.80M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 16.58B |
| Total Expenses (Quarterly) | 17.92B |
| EPS Diluted (Quarterly) | -0.5405 |
| Enterprise Value | 402.09B |
| Gross Profit Margin (Quarterly) | 71.51% |
| Profit Margin (Quarterly) | -8.06% |
| Earnings Yield | 0.87% |
| Operating Earnings Yield | 3.49% |
| Normalized Earnings Yield | 2.102 |